Df. Sahm et al., Multidrug-resistant urinary tract isolates of Escherichia coli prevalence and patient demographics in the United States in 2000, ANTIM AG CH, 45(5), 2001, pp. 1402-1406
Concurrent resistance to antimicrobials of different structural classes has
arisen in a multitude of bacterial species and may complicate the therapeu
tic management of infections, including those of the urinary tract. To asse
ss the current breadth of multidrug resistance among urinary isolates of Es
cherichia coli, the most prevalent pathogen contributing to these infection
s, all pertinent results in The Surveillance Network Database-USA from 1 Ja
nuary to 30 September 2000 were analyzed. Results were available for 38,835
urinary isolates of E, coli that had been tested against ampicillin, cepha
lothin, ciprofloxacin, nitrofurantoin, and trimethoprim-sulfamethoxazole. O
f these isolates, 7.1% (2,763 of 38,835) were resistant to three or more ag
ents and considered multidrug resistant. Among the multidrug-resistant isol
ates, 97.8% were resistant to ampicillin, 92.8% were resistant to trimethop
rim-sulfamethoxazole, 86.6% were resistant to cephalothin, 38.8% were resis
tant to ciprofloxacin, and 7.7% were resistant to nitrofurantoin. The predo
minant phenotype among multidrug-resistant isolates (57.98; 1,600 of 2,793)
included resistance to ampicillin, cephalothin, and trimethoprim-sulfameth
oxazole. This was the most common phenotype regardless of patient age, gend
er, or inpatient-outpatient status and in eight of the nine U,S, Bureau of
the Census regions. Rates of multidrug resistance were demonstrated to be h
igher among males (10.4%) than females (6.06%), among patients > 65 years o
f age (8.7%) than patients less than or equal to 17 (6.8%) and 18 to 65 (6.
1%) years of age, and among inpatients (7.6%) than outpatients (6.9%), Regi
onally, the rates ranged from 4.3% in the West North Central region to 9.2%
in the West South Central region, Given the current prevalence of multidru
g resistance among urinary tract isolates of E. coil in the United States (
7.1%), continued local, regional, and national surveillance is warranted.